NewAmsterdam Pharma Company
NAMS
#3860
Rank
C$3.63 B
Marketcap
$34.00
Share price
0.64%
Change (1 day)
19.97%
Change (1 year)

NewAmsterdam Pharma Company (NAMS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$86.54 Million

According to NewAmsterdam Pharma Company's latest financial reports the company's total liabilities are C$86.54 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

NewAmsterdam Pharma Company - Total liabilities on balance sheet (from 2023 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$77.86 M10.45%
2022-12-31C$70.49 M331.77%
2021-12-31C$16.32 M-33.92%
2020-12-31C$24.7 M